Intracellular K⁺ decreases during pectoral fin bud growth. by Xiaowen Jiang (8291814)

All-variable XGBoost model on the ‘significant illness’ binary using the primary decision-maker dataset. by Richard Barrett-Jolley (739341)

<i>neurod1</i>^<i>ΔUCE</i> homozygous mutants display a decrease in the expression of several EE hormones. by Anne Sophie Reuter (12239993)

Immunohistochemistry of Ki67, PCNA, and α-SMA was performed on the VX2 tumor rabbit model at days 1, 2, 5 and 7 after nsPEF ablation. by Qing-Gang Li (273341)

Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production. by Bei Wang (116772)

HA-MAD1 tumors have increased CIN and decreased p53. by Sarah E. Copeland (13951506)

Pre-exposure to mRNA-LNPs leads to overall decrease of antigen levels. by Zhen Qin (411748)

Defects in RNA-mediated TDP-43 self-assembly decrease nuclear localization. by Patricia M. dos Passos (18078809)

Apicoplast inhibitors decrease global parasite prenylation in the second IDC after treatment. by Kit Kennedy (4915510)

Exercise is associated with a decrease in BMI. by Stephanie Y. Yang (8384520)

“…<p>There was a significant association between a greater number of exercise sessions attended and decreased BMI over the 6-month intervention period.…”

siRNA-mediated knockdown of myosin-9 decreases reovirus infection and egress. by Isabel Fernández de Castro (22431012)

Increasing BMI is associated with decreases in multiple leukocyte subsets in the peripheral blood of ccRCC subjects, whereas only classical monocytes and regulatory T cells are dim... by Justin T. Gibson (8910317)

Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Deletion of <i>ERG251-A</i> but not <i>ERG251-B</i> leads to decreased filamentation. by Xin Zhou (54275)

Loss of Vps34 is associated with decreased eTreg survival but intact activation. by Erienne G. Norton (9612079)

Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

Subjects:

Scenario analysis for daratumumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

Subjects:

Newly occurring LTSA-MD cases in workers for over a month. by Yasuhiko Deguchi (3167955)

Subjects:

Structure-based alignment and homology modelling of MeTIR domains. by Bulelani L. Sizani (21485746)